Federal award
HEXAMER THERAPEUTICS INC.
HT942523C0078
Contract
Obligated and Ceiling
- Obligated (net)
- $3,928,061.02
- Ceiling (potential value, not spending)
- $3,928,061.02
- Current value
- $3,928,061.02
- Gross positive obligations
- $3,928,061.22
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- HEXAMER THERAPEUTICS INC. · MK8HSFMVB647
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- HEXAMER THERAPEUTICS INC. · MK8HSFMVB647
- Awarding agency
- Department of War · sub-agency 97DH · office HT9427
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- AN11 · HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH
- Industry (NAICS)
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- PIID
- HT942523C0078
- Award type code
- D
- Actions
- 6 · Sep 25, 2023 to Jun 3, 2026
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History6
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jun 3, 2026 | FY2026 | P00005 | B | $0.00 | — |
| Apr 29, 2026 | FY2026 | P00004 | M | $0.00 | — |
| Nov 25, 2025 | FY2026 | P00003 | B | $0.00 | — |
| Mar 27, 2025 | FY2025 | P00002 | D | $0.00 | — |
| Nov 27, 2023 | FY2024 | P00001 | B | −$0.20 | — |
| Sep 25, 2023 | FY2023 | 0 | — | $3,928,061.22 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.